Modulated release from biocompatible polymers

• US 6,531,154 B1
• Filed: 06/09/1998
• Issued: 03/11/2003
• Est. Priority Date: 06/10/1997
• Status: Expired due to Term

• Current Assignee: Brown University
• Original Assignee: Brown University
• Inventors: Webber, Wendy L., Thanos, Christopher G., Mathiowitz, Edith
• Primary Examiner(s): Webman, Edward J.
• Application Number:
  US09/093,868
• Time in Patent Office: 1,736 Days
• Field of Search: 424/487, 424/486, 424/501, 424/443-44, 424/449, 424/426, 424/428, 424/469-70, 424/457
• US Class Current: 424/487
• CPC Class Codes: A61K 9/1611 Inorganic compounds
• CPC Class Codes: A61K 9/1647 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: A61K 9/2009 Inorganic compounds
• CPC Class Codes: A61K 9/204 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: A61K 9/7007 Drug-containing films, membranes or sheets A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence

Abstract

Sustained delivery compositions which modulate the release of incorporated prophylactic, therapeutic, and/or diagnostic agents, and methods of preparation and use thereof, are disclosed. The compositions include a biocompatible polymeric matrix; a prophylactic, therapeutic, and/or diagnostic agent dispersed within the polymeric matrix; and a monovalent cation component which is separately dispersed within the polymeric matrix. The monovalent cation component modulates the release of the incorporated agent from the polymeric matrix. The compositions can be prepared by dissolving a biocompatible polymer in a solvent to form a polymer solution, and separately dispersing a monovalent cation and a prophylactic, therapeutic, and/or diagnostic agent within the polymer solution. The polymer solution is then solidified to form a polymeric matrix, wherein a significant amount of the monovalent cations is dispersed in the polymeric matrix separately from the incorporated agent. The cation modulates the release of the incorporated agent from the polymeric matrix.

Claims

1. A composition for the modulated release of a prophylactic, therapeutic, or diagnostic agent, comprising:

a) a biocompatible and biodegradable polymeric matrix;

b) an effective amount of a prophylactic, therapeutic, or diagnostic agent dispersed within the polymeric matrix; and

c) at least one metal monovalent cation for modulating release of the agent from the polymeric matrix, wherein the monovalent cation is obtained from a water-soluble salt and is separately dispersed within the polymeric matrix in the form of particles having a size less than 100 μ

m,

wherein the cation is dispersed in a form and amount effective to swell the polymeric matrix and to provide a defined pattern of release of the agent from the matrix over a period of time between one day and nine months, when the matrix is placed in an aqueous solution.

2. The composition of claim 1 further comprising more than one monovalent cation.

3. The composition of claim 2 wherein both cations are obtained from a water-soluble salt.

4. The composition of claim 1 wherein the cation is obtained from sodium chloride.

5. The composition of claim 1 wherein the polymer further comprises non-biodegradable polymers.

6. The composition of claim 5 wherein the non-biodegradable polymer is selected from the group consisting of polyacrylates, copolymers of polymers of ethylene-vinyl acetates and acyl substituted cellulose acetates, non-degradable polyurethanes, polystyrenes, polyvinyl chloride, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonate polyolefins, polyethylene oxide, copolymers thereof, and blends thereof.

7. The composition of claim 1 wherein the biodegradable polymer is selected from the group consisting of poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s, poly(lactic acid)s, poly(glycolic acid)s, poly(lactic acid-co-glycolic acid)s, polyanhydrides, polyorthoesters, polyetheresters, polycaprolactone, polyesteramides, polyurethanes, copolymers thereof, and blends thereof.

8. The composition of claim 1 wherein the polymer is selected from the group consisting of blocked polymers, unblocked polymers, and blends thereof.

9. The composition of claim 1 wherein the agent comprises a protein.

10. The composition of claim 1 wherein the agent comprises an antibiotic.

15. The composition of claim 1 wherein the particles of monovalent cation component have a size less than about 50 μ

m.

16. The composition of claim 15 wherein the particles of monovalent cation component have a size less than about 20 μ

m.

17. The composition of claim 16 wherein the particles of monovalent cation component have a size less than about 5 μ

m.

18. The composition of claim 1 wherein the prophylactic, therapeutic, or diagnostic agent is in the form of particles less than about 5 μ

m.

19. The composition of claim 1 in a form selected from the group consisting of thin films, pellets, cylinders, discs, and microparticles.

11. A composition for the modulated release of a biologically active agent, comprising:

a) a biocompatible polymeric matrix of a poly(lactide-co-glycolide) polymer;

b) an effective amount of a biologically active agent dispersed within the polymeric matrix; and

c) a monovalent cation component for modulating release of the biologically active agent from the polymeric matrix, wherein the monovalent cation component is separately dispersed within the polymeric matrix in the form of particles having a size less than 100 μ

m,

wherein the cation is dispersed in a form and amount effective to swell the polymeric matrix and to provide a defined pattern of release of the agent from the matrix over a period of time between one day and nine months, when the matrix is placed in an aqueous solution.

12. The modulated release composition of claim 11 wherein the monovalent cation component is obtained from a salt selected from the group consisting of metal halides.

13. The modulated release composition of claim 11 wherein the biologically active agent is a protein selected from the group consisting of nucleases, erythropoietin, human growth hormone, interferons, interleukins, growth factors, adrenocorticotropic hormone, tumor necrosis factor, and colony-stimulating factors.

14. The modulated release composition of claim 11 wherein the biologically active agent is an antibiotic.